Alcohol Use Disorder clinical trials
Showing 51–100 of 222 active trials. Describe your situation to see which ones you may be eligible for.
- Image-guided, Robot Navigated Transcranial Magnetic Stimulation (IR-TMS) for Alcohol Use Disorder (AUD)
- Trial of a Culturally Informed Brief Intervention to Reduce Alcohol Related Health Disparities and Treatment Inequities Among Latinxs
- Virtual Reality (VR) NATURE - Alcohol Use Disorder (AUD)
- A Combined Neurofeedback-TMS Intervention for Alcohol Use Disorder
- Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
- Alcohol-ROC-Training
- Non-invasive Vagal Nerve Stimulation as Novel Treatment to Improve Functional Outcomes in Veterans With Alcohol Use Disorder
- Tirzepatide in MetALD
- Neuromodulation and Cognitive Training for Substance Use Disorders
- Piloting a Deaf Accessible Pre-Treatment for AUD
- Wellness, Alcohol, Vitals, and Emotions
- Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD)
- Virtual Incentive Treatment for Alcohol
- rTMS as Add on Treatment for Substance Use Disorders
- StuDy AimED at Increasing AlCohol AbsTinEnce
- Pregnenolone for the Treatment of Alcohol Use Disorder
- Prazosin for Alcohol Use Disorder With Withdrawal Symptoms
- Evaluating Caregiver Involvement in Primary Care-Based Brief Interventions for Adolescent Alcohol Use Problems
- Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
- Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH
- MPFC Theta Burst Stimulation as a Treatment Tool for Alcohol Use Disorder: Effects on Drinking and Incentive Salience
- Study of NTX-2001 on Alcohol Consumption in Alcohol Use Disorder
- Mobile Platform for Optimizing Wellness and Engagement in Recovery
- Alpha-1 Blockade for Alcohol Use Disorder (AUD)
- Brief Family Involved Treatment Telehealth
- Emergency Department-Initiated Medications for Alcohol Use Disorder
- Study of Tirzepatide for Recovery and Alcohol Use Management
- Diclofenac Dose Response Study
- Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)
- An Effectiveness Trial of the PrEP for WINGS Study
- LGG Supplementation in Patients With AUD and ALD
- The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration
- Suvorexant for Treatment of AUD and PTSD
- GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
- A Randomized Controlled Trial of Digital CBT to Treat Addiction: Digital RITch®CBT vs. Standard CBT
- Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
- Multi-Component Breath Alcohol Intervention Phase 3
- A Reinforced Mindfulness-Based Intervention to Reduce Problematic Drinking Among Hispanic Emerging Adults
- Game-Based Intervention to Reduce Alcohol Use Among Youth
- Acute Alcohol Response In Bipolar Disorder: a Longitudinal Alcohol Administration/fMRI Study
- Guanfacine for Alcohol Use Disorder (AUD)
- Gathering Online for Dialogue and Discussion to Enhance Social Support
- Renewed Recovery: a Pilot Test of a Web-Based Mindfulness-Based Relapse Prevention Continuing Care Intervention for Alcohol Use Disorder
- The Less is More Study
- Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention
- HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)
- MiREA-AC for Reducing Problematic Alcohol and Marijuana Use in College Students
- Transition Health and Resilience Through Valued Experiences (THRiVE) Pilot for Newly Separated Veterans
- Testing the Impact of Thrive App Versions on Alcohol Use and Posttraumatic Stress After Recent Sexual Assault
- PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.